💊Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device November 07, 2017
Osaka, Japan and Cambridge, MA – November 7, 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502) and Portal Instruments today announced a collaboration to develop and commercialize Portal’s needle-free drug delivery device for potential use with Takeda’s investigational or approved biologic medicines. The Portal device was developed at the Massachusetts Institute of Technology (MIT) in the laboratory of Professor Ian Hunter. The technology has the potential for applications across a range of biologic medicines that currently require administration through an injection.
https://www.takeda.com/newsroom/newsreleases/2017/portal-instruments/